๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Visakhapatnam
Clinical trial register · India

Clinical Trials in Visakhapatnam

Every study on the ClinicalTrials.gov registry that lists a site in India and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage โ€” all 1123 matching records held by the registry are in this view. Synced 21 Sep 2026, 03:16 UTC
1123
Studies in scope
all four open statuses
610
Recruiting now
open to new participants
222
Lead sponsors
across recruiting studies
Top sites
New Delhi 332 Mumbai 259 Hyderabad 237 Bangalore 193 Pune 189
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Aurigene Discovery Technologies Limited2 AstraZeneca2 Novo Nordisk A/S2 Natureceuticals Sdn Bhd2 Centre for Chronic Disease Control, India1
Site location
New Delhi332 Mumbai259 Hyderabad237 Bangalore193 Pune189
All 274 locations
Target enrolment
to
25 of 1123 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Indian sites
Start
Not yet open
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
NCT07784270Obesity or Overweight, Diabetes Mellitus, Type 2
AstraZeneca
Phase 3
1,500
Bangalore, Indore, Kolkata, Nagpur, Pune, Siliguri, Visakhapatnam
2026-08-21
Recruiting
A Phase 3 Study in India to Describe the Safety and Immunogenicity of RSVpreF
NCT07653100Respiratory Syncytial Virus (RSV)
Pfizer
Phase 3
540
Visakhapatnam, Bangalore, Belagavi, Nashik, Dwarka, New Delhi, Jaipur, Chengalpattu
2026-06-22
Not yet open
National Institute for Health and Care Research Global Health Research Centre for Multiple Long-Term Conditions
NCT07582380Chronic Conditions, Multiple, Diseases of the Circulatory System, Diseases of the Respiratory System, Endocrine, Nutritional and Metabolic Diseases
Centre for Chronic Disease Control, India
Not applicable
3,600
Visakhapatnam, Sonฤซpat, Phalodi
2026-05-05
Recruiting
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 โ‰ฅ 50%. (ROSETTA Lung-202)
NCT07361510Non-Small Cell Lung Cancer (NSCLC)
Bristol-Myers Squibb
Phase 3
750
Eluru, Visakhapatnam, Goraj, Mumbai, Nagpur, Dwarka, Hyderabad, Delhi
2026-03-12
Recruiting
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
NCT07216703Cervical Cancer
Merck Sharp & Dohme LLC
Phase 3
1,023
Visakhapatnam, Belagavi
2026-01-19
Not yet open
This is a Multicentre International Study Evaluating CT-based IGABT With / Without Either TRUS During BT/Pre BT MR as Per IBS-GECESTRO-ABS Recommendations for Target contouring-as an Alternative to MRIGABT for Cervical Cancer From Implementation Perspectives Under EMBRACE-III:TRIPLET IMPACT Study.
NCT07249021Locally Advanced Cervical Cancer, Brachytherapy, CT, Transrectal Ultrasound
Homi Bhabha Cancer Hospital & Research Centre
Observational
1,200
Visakhapatnam
2025-11
Recruiting
Nuvastaticยฎ Phase III Trial for Fatigue in Triple-Negative Breast Cancer
NCT07669467Fatigue Related to Cancer Treatment, Breast Cancer
Natureceuticals Sdn Bhd
Phase 3
250
Visakhapatnam, Mysore, Jalgaon, Pune, Erode, Kanpur
2025-10-01
Recruiting
A Randomized, Double-blind, Placebo-controlled, Parallel-group, Comparative, Phase III Study to Evaluate the Efficacy and Safety of Nuvastaticยฎ 300mg Capsule in Reducing Cancer-Tumor in Patients With Metastatic Colorectal Cancer Receiving Standard Chemotherapy.
NCT07669454Fatigue Related to Cancer Treatment, Colon Cancer
Natureceuticals Sdn Bhd
Phase 3
250
Visakhapatnam, Mysore, Jalgaon, Pune, Erode, Kanpur
2025-10-01
Active, closed
Effects of a Financial Literacy and Gender-Transformative Couples Intervention on Parenting Practices in India
NCT07651670Parenting Practices, Intimate Partner Violence (IPV), Mental Health, Empowerment
Shruti Shukla
Not applicable
4,552
Visakhapatnam, Mumbai, Jaipur, Noida
2025-07-29
Recruiting
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
NCT06875310Carcinoma, Non-Small-Cell Lung
Mirati Therapeutics Inc.
Phase 3
630
Visakhapatnam, Ahmedabad, Thiruvananthapuram, Mumbai, New Delhi, Bhubaneswar, Madurai, Hyderabad
2025-04-24
Active, closed
A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative Colitis
NCT06867094Colitis Ulcerative
Sanofi
Phase 2
204
Hyderabad, Jaipur, Kolkata, Ludhiana, Secunderabad, Surat, Visakhapatnam
2025-03-28
Recruiting
The Chronic Kidney Disease Adaptive Platform Trial Investigating Various Agents for Therapeutic Effect
NCT06058585Chronic Kidney Diseases
The George Institute
Phase 3
1,000
Visakhapatnam, Patna, Raipur, Dehradun, Ahmedabad, Mangaluru, Meppฤdi, Indore
2024-09-04
Active, closed
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
NCT06118281Cardiovascular Risk, Acute Myocardial Infarction (AMI)
Novo Nordisk A/S
Phase 3
10,000
Guntur, Visakhapatnam, Raipur, Ahmedabad, Surat, Vadodara, Bengaluru, Mangaluru
2024-06-25
Active, closed
A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and Inflammation
NCT06200207Heart Failure, Systemic Inflammation
Novo Nordisk A/S
Phase 3
680
Vijayawada, Visakhapatnam, Vadodara, Belagavi, Bengaluru, Mysuru, Udupi, Nagpur
2024-04-01
Active, closed
A Phase 2a Study of HT-6184 in Subjects With IPSS-R Very Low, Low or Intermediate Risk MDS and Anemia
NCT07052006Myelodysplastic Syndrome, Anemia in Myelodysplastic Syndromes
Halia Therapeutics, Inc.
Phase 2
37
Ahmedabad, Kannur, Visakhapatnam, Kolhฤpur, Dehradun, Madurai, Hyderabad, Kolkata
2023-12-09
Recruiting
A Study Evaluating the Safety and Efficacy of AUR108 in Patients With Relapsed Advanced Lymphomas (ASHA-1)
NCT05984147Relapsed Advanced Lymphomas
Aurigene Discovery Technologies Limited
Phase 1
40
Visakhapatnam, Chandigarh, Ahmedabad, Surat, Rohtak, Srinagar, Belagavi, Kochi
2023-10-19
Recruiting
A Study Evaluating the Safety and Efficacy of AUR107 in Patients With Relapsed Advanced Malignancies (SHAKTI-1)
NCT05865002Relapsed Malignant Solid Neoplasm
Aurigene Discovery Technologies Limited
Phase 1
50
Vijayawada, Visakhapatnam, Chandigarh, Ahmedabad, Surat, Rohtak, Bangalore, Mysore
2023-09-05
Active, closed
Oregovomab Plus Chemotherapy in Neo-adjuvant Setting in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer
NCT05605535Ovarian Neoplasm Epithelial, Ovarian Cancer, Fallopian Tube Neoplasms, Peritoneal Carcinoma
CanariaBio Inc.
Phase 2
88
Visakhapatnam, Vadodara, Belagavi, Kochi, Trivandrum, Puducherry, Jaipur, Chennai
2023-02-07
Active, closed
A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic Cough
NCT05600777Cough, Refractory Chronic Cough
Bellus Health Inc. - a GSK company
Phase 3
997
Belagavi, Faridabad, Nagpur, Nashik, Visakhapatnam
2022-12-05
Recruiting
A Study to Learn More About How Safe Darolutamide is and How Well it Works Under Real World Conditions When Taken in Addition to Standard Androgen Deprivation Therapy (ADT) in Indian Participants With High-risk Non-metastatic Castration-resistant Prostate Cancer (nmCRPC)
NCT05348876Non-metastatic Castration-resistant Prostate Cancer
Bayer
Phase 4
50
Vijayawada, Visakhapatnam, Nadiฤd, Surat, Belagavi, Bengaluru, Kochi, Thiruvananthapuram
2022-08-03
Active, closed
A Study of GRC 54276 in Participants With Advanced Solid Tumors and Lymphomas.
NCT05878691Advanced Solid Tumor, Lymphoma
Glenmark Specialty S.A.
Phase 1
320
Vijayawada, Visakhapatnam, Gurgaon, Bangalore, Bengaluru, Kannur, Aurangabad, Mumbai
2022-06-28
Active, closed
A Phase-3, Open-Label, Randomized Study of Dato-DXd Versus Investigator's Choice of Chemotherapy (ICC) in Participants With Inoperable or Metastatic HR-Positive, HER2-Negative Breast Cancer Who Have Been Treated With One or Two Prior Lines of Systemic Chemotherapy (TROPION-Breast01)
NCT05104866Breast Cancer
AstraZeneca
Phase 3
732
Gurgaon, Howrah, Hyderabad, Jaipur, Kolkata, Nashik, Surat, Visakhapatnam
2021-10-18
Active, closed
Ovarian Suppression Evaluating Subcutaneous Leuprolide Acetate in Breast Cancer
NCT04906395Breast Cancer
Tolmar Inc.
Phase 3
250
Vijayawada, Visakhapatnam, Ahmedabad, Surat, Bengaluru, Mysore, Nagpur, Nashik
2021-07-01
Recruiting
Perioperative Respiratory Care and Outcomes for Patients Undergoing High Risk Abdominal Surgery
NCT04256798Infection, Pneumonia, Surgical Site Infection, Wound Infection
University of Birmingham
Phase 3
12,942
Visakhapatnam, Srinagar, Chinchpฤda, Madhava Nagar, Patiฤla, Bhubaneswar, Chandigarh, Jodhpur
2020-11-13
Active, closed
A Study of Intravesical BCG in Combination With ALT-803 in Patients With Non-Muscle Invasive Bladder Cancer
NCT02138734Non-muscle Invasive Bladder Cancer
ImmunityBio, Inc.
Phase 1/2
369
Visakhapatnam, Adyฤr, Ahmedabad, Aurangabad, Nagpur, Pune, Mumbai, New Delhi
2014-07-21
Rows per page Showing 1–25 of 25
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Indian investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 21 September 2026. https://priyalifescience.com/clinical-trials-india/city/visakhapatnam

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.